Pharmaceutical Filtration Market

The global pharmaceutical filtration market is largely driven by factors such as nano fibre technological advancements, generic market growth, regulatory guidelines for pharmaceutical production cleanrooms, and increasing production of large biologics and molecules. An increasing R&D budget by major biopharmaceutical organisations also goes a long way in boosting the overall profile of the pharmaceutical filtration market. The pharmaceutical filtration market is anticipated to be worth more than US$ 17 billion by the end of the forecast period in 2022.

Membrane Filters a Focus Area in the Pharmaceutical Filtration Market

The membrane filters segment comprise more than a third of the revenue share in the pharmaceutical filtration market by product type in 2017 and are predicted to remain strong going forward. A robust CAGR of more than 6% from 2017 to 2022 all but ensures that this segment has its best days ahead of it in the pharmaceutical filtration market. Prefilters and depth media filters are the second most popular product type with a revenue share slightly over a fifth of the pharmaceutical filtration market. The North America prefilter and depth media filters market alone is more than a third of the global total which is why companies would be advised to focus their attention on this region of the pharmaceutical filtration market.

Download a Comprehensive Report Snapshot

Manufacturing Scale Segment Has Major Share in the Pharmaceutical Filtration Market

The manufacturing scale segment accounts for a revenue share exceeding half of the pharmaceutical filtration market by operation segment and is likely to remain dominant in the forecast period. The manufacturing scale segment is on track to grow to more than US$9.3 billion by end 2022, making it imperative for companies to target this operation segment in the pharmaceutical filtration market. Nonetheless, the pilot scale segment is standing strong in second place with a revenue share nearing a third of the pharmaceutical filtration market by operation. The largest opportunity in the pilot scale segment is undoubtedly in North America as the continent is already the largest market coupled with the highest projected CAGR.

Final Product Processing and Raw Material Filtration Key in Pharmaceutical Filtration Market

Final product processing and raw material filtration account for the lion’s share of the pharmaceutical filtration market in terms of application segment and companies should make their long-term business plans keeping this in mind. Companies specializing in final product processing are advised to invest in North America and Europe as both these developed regions are poised to exceed a value of US$ 1.5 billion by the end of the forecast period. The same holds true for the raw material filtration segment as well. However, APEJ can prove very lucrative if all the factors prove conducive and key stakeholders should not overlook this region entirely in favour of either North America or Europe.

Competition Dashboard in the Pharmaceutical Filtration Market

Future Market Insights has profiled a few of the companies that have shaped the pharmaceutical filtration market. These include 3M Companies, Amazon Filters, Eaton Corporation Plc. GE Healthcare Inc., Merck KGaA, Pall Corporation, Parker Hannifin Corporation, Meissner Filtration Products, Sartorius Stedim Biotech, and The Marmon Group LLC.